On page 59 of the programme for Government, there is a reference to a cystic fibrosis, CF, model of care. Last Friday, Cystic Fibrosis Ireland stated on its website that the HSE had approved the treatment of the underlying cause of CF for 80% of the CF population. Trikafta is the first approved treatment that is effective for CF patients aged 12 years and over, with at least one Delta-F508 gene mutation, which affects up to 80% of the CF population in Ireland, as was stated. This is subject to approval of the drug by the European Medicines Agency. Once the approval has been sanctioned, will the Taoiseach indicate the timeline that will be put in place so that we will see patients availing of this drug?

I thank Deputy Neville for his question. I know he has a real interest in cystic fibrosis and improving services for CF patients. I do not know the timeframe but I will check it out and make sure the Deputy gets a reply.

Let me say to those who are here and those who are not here, that those who had questions today will not be top of the list tomorrow. Deputy Crowe will be in tomorrow.